A novel signature based on cerna and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients

HIGHLIGHTS

  • who: Wei Cao and collaborators from the Nantong University, China have published the paper: A novel signature based on CeRNA and immune status predicts prognostic risk and drug sensitivity in gastric cancer patients, in the Journal: (JOURNAL)
  • what: The authors constructed two ceRNA regulatory networks, circRNA-miRNA-mRNA and_(circRNA, lncRNA)-miRNA based on circRNA, to further explore the molecular mechanism of GC. The authors showed that RCAN2 was survival analysis of the model showed that the overall survival time of the high-risk group was significantly lower than that of the lowrisk group (P . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?